How much did Boston Scientific spend on buybacks in fiscal 2022?

$0, according to its 10-K for the fiscal year ending Dec 31, 2022.

Is Boston Scientific's share count going down?

Its diluted share count changed +5.5% over five fiscal years and −1.3% over the last year.

Its filings show $3.0B remaining under its repurchase authorization as of Jun 30, 2026.

Companies / Health Care / Health Care Equipment

BSX

$0bought back in the 12 months to Jun 30, 2026

Boston Scientific didn’t buy back any stock in the last twelve months.

Stock repurchases by quarter

Show as table

Diluted shares outstanding

Show as table

$0last quarter (Q2 2026)

−$320Mnet of stock compensation ($320M)

−1.3%diluted shares, 1 year

+5.5%diluted shares, 5 years

$0dividends, 12 months

0%of free cash flow ($3.6B) spent on buybacks

$0raised by issuing stock, 12 months

$3.0Bleft under its authorization as of Jun 30, 2026

Fiscal year	Buybacks	Dividends	Stock pay	Free cash flow	Diluted shares	Filing
2022	$0	$55M	$220M	$938M	1.44B	10-K
2021	$0	$55M	$194M	$1.3B	1.43B	10-K
2020	$535M	$28M	$170M	$1.1B	1.42B	10-K
2019	$0	$0	$157M	$1.4B	1.41B	10-K
2018	$0	$0	$140M	−$6M	1.40B	10-K
2016	$0	—	$116M	$806M	1.38B	10-K
2015	$0	—	$107M	$444M	1.34B	10-K
2014	$125M	—	$103M	$1.0B	1.32B	10-K
2013	$500M	—	$105M	$865M	1.34B	10-K
2012	$600M	—	$108M	$1.1B	1.41B	10-K

Does Boston Scientific buy back its stock?: Boston Scientific didn’t buy back any stock in the last twelve months.
How much did Boston Scientific spend on buybacks in fiscal 2022?: $0, according to its 10-K for the fiscal year ending Dec 31, 2022.
Is Boston Scientific's share count going down?: Its diluted share count changed +5.5% over five fiscal years and −1.3% over the last year.
Does Boston Scientific have a buyback authorization?: Its filings show $3.0B remaining under its repurchase authorization as of Jun 30, 2026.

Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 3, 2026 · open on SEC.gov